Oncology intelligence delivered.

About 88% of actionable oncology data lives in unstructured sources such as clinical notes, pathology and radiology reports, and scanned documents. Tools that only read structured fields miss most of the information needed to act. OncoLens reads the whole record.

OncoLens leverages AI to analyze structured and unstructured EMR data, enabling timely identification of patients eligible for advanced diagnostics, clinical trials, or targeted therapies. The OncoLens platform supports precision oncology by streamlining patient ID workflows and surfacing key insights directly within provider and research team workflows.

Clinical trial matching can be delayed by fragmented data and manual screening. OncoLens automates patient-to-trial matching by aligning trial I/E criteria with real-world EMR data. As an oncology-focused platform, OncoLens goes deep into the nuances of cancer care, including lines of therapy, indications of progression, and more. This improves trial feasibility, reduces manual screening, and helps life sciences partners and cancer centers connect the right patients to the right trial at the right time.

Tumor board operations are often slowed by manual intake, inconsistent documentation, and redundant reporting tasks. OncoLens streamlines every step from case intake and CME tracking to accreditation reporting, cutting down administrative burden and boosting cross-team efficiency.

By combining clinical, pathology, and biomarker data, OncoLens delivers actionable insights into treatment patterns, care gaps, and demographic trends. Through large language models tailored with proprietary OncoLens oncology knowledge models, these insights go deep, capturing lines of therapy, progression, and contextual information on the patient. Life sciences teams and cancer centers use these analytics to inform trial design, evaluate performance, and drive quality improvement.

The OncoLens Research Network connects life sciences companies with community and academic cancer centers. This partnership enables access to diverse patient populations, AI-driven patient matching, streamlined research workflows, highly curated industry trials, and revenue-generating opportunities.

OncoLens integrates with leading EMRs to extract and standardize key data elements used in registry reporting. OncoLens automation tools reduce manual abstraction, improve data quality, and support compliance with accreditation standards for cancer programs.

The OncoLens platform enables life sciences partners and oncology providers to coordinate on clinical trials, quality initiatives, and real-world data projects. White-glove support from OncoLens ensures transparency, alignment, and smooth execution from feasibility through closeout.

OncoLens aggregates structured and unstructured data from EMRs, pathology systems, and lab reports. This enables providers and life sciences teams to access a holistic view of the patient journey, identify trends, and unlock insights to guide treatment, research, and operational decisions.

OncoLens enables scalable precision oncology by combining automated data extraction, AI-based matching, and robust analytics across multiple cancer centers. Whether for targeted therapies, biomarker tracking, or real-world evidence generation, OncoLens helps both providers and sponsors execute with confidence.